| Catalog_no | ADMC0671 |
| Product_name | Anacetrapib(MK0859) |
| Category | 抑制剂与激动剂 |
| Size | 10mg/50mg/100mg |
| Price | 2220.00/6440.00/10880.00 |
| Specificity | Target: CETP. Fields: Anacetrapib (MK0859) is a potent, selective, reversible rhCETP and mutant CETP(C13S) inhibitor with IC50 of 7.9 nM and 11.8 nM, increases HDL-C and decreases LDL-C, does not increase aldosterone or blood pressure. Phase 3. |
| Dilution | IC50: 7.9±2.5 nM (rhCETP), 11.8±1.9 nM (CETPC13S)[1] |
| Purification | >98% |
| Concentration | 靶点：CETP;IC50： 7.9±2.5 nM (rhCETP), 11.8±1.9 nM (CETPC13S)[1] |
| Storage_stability | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername | MK-0859, MK 0859, MK0859 |
| Observed_band | 637.51 |
| Notes | Anacetrapib (MK0859) is a potent, selective, reversible rhCETP and mutant CETP(C13S) inhibitor with IC50 of 7.9 nM and 11.8 nM, increases HDL-C and decreases LDL-C, does not increase aldosterone or blood pressure. Phase 3. |
| Instructions | 
查看与下载 |
| Share |
|
